| 标题 |
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Guoming Shi; Xiaoyong Huang; Xiaowu Li; Fei Liang; Qiang Gao; et al 出版日期:2025-08-29 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)